C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes

Annals of Neurology

Volumn 56, Issue 6, 2004, Pages 827-835

  Kamiya, Hideki ^a   Zhang, Weixian ^a   Sima, Anders A F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CALCITONIN GENE RELATED PEPTIDE; INSULIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROPEPTIDE; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR; SOMATOMEDIN C; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CONTROLLED STUDY; DIABETIC NEUROPATHY; HYPERALGESIA; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MORPHOMETRICS; NERVE DEGENERATION; NERVE FUNCTION; NOCICEPTION; NONHUMAN; NONMYELINATED NERVE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SCIATIC NERVE; SENSORY DYSFUNCTION; SENSORY NEUROPATHY; SPINAL GANGLION; SUBSTITUTION THERAPY; SURAL NERVE; TISSUE LEVEL;

ANIMALS; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; MALE; RATS; RATS, INBRED BB;

EID: 9644264237     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20295     Document Type: Article

References (59)

1. Sima AAF. Physiologicat and pathophysiological significance of C-peptide actions. Exp Diabesity Res 2004;5:1-96.
2. Rubenstein A, Clark J, Melani F, Steiner D. Secretion of proinsulin C-peptide by pancreatic β cells and its circulation in blood. Nature 1969;224:697-699.
3. +-ATPase and diabetes. Exp Diabesity Res 2004;5:37-50.
4. Zhang W, Yorek M, Pierson CR, et al. Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat. Exp Diabesity Res 2001;2:187-194.
5. +-ATPase activity in diabetes mellitus type 1. Clin Sci 2000;98:283-290.
6. Jensen ME, Messina EJ. C-peptide induces a concentration-dependent dilatation of skeletal muscle arterioles only in the presence of insulin. Am J Physiol 1999;276:H1223-H1228.
7. Grunberger G, Qiang X, Li Z-G, et al. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 2001;44: 1247-1257.
8. Riegler R, Pramanik A, Jonasson P, et al. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A 1999;96:13318-13323.
9. Grunberger G, Sima AAF. The C-peptide signaling. Exp Diabesity Res 2004;5:26-36.
10. Ekberg K, Brismar T, Johansson BL, et al. Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 2003;52:536-541.
11. Johansson BL, Borg K, Fernquist-Forbes E, et al. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 1996;39:687-695.
12. Johansson BL, Borg K, Fernquist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 2000;17: 181-189.
13. Zierath J, Handberg A, Tally M, Wallberg-Henriksson H. C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 1996;39:306-313.
14. Sima AAF, Zhang W-X, Sugimoto K, et al. C-peptide prevents and improves chronic type 1 diabetic neuropathy in the BB/Wor-rat. Diabetologia 2001;44:889-897.
15. Sima AAF, Zhang W, Li ZG, et al. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide. Diabetes 2004;53: 1556-1563.
16. Sima AAF. C-peptide and diabetic neuropathy. Expert Opin Investig Drugs 2003;12:1471-1488.
17. Pierson CR, Zhang W, Sima AAF. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropath Exp Neurol 2003;62: 765-779.
18. Li Z-G, Zhang W, Sima AAF. C-peptide enhances insulin-mediated cell growth and protection against high glucose induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev 2003;19:375-385.
19. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;19:52-58.
20. Kapur D. Neuropathic pain and diabetes. Diabetes Metab Res Rev 2003;19:S9-S15.
21. Dyck PJ, Lambert EH, O'Brien PC. Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology 1976;26:466-471.
22. Woolf CJ, Shordand P, Reynolds M, et al. Reorganization of central terminals of myelinated primary afferents in rat dorsal horn following peripheral axotomy. J Comp Neurol 1995;360: 121-134.
23. Levi-Montalcini R, Dal Toso R, detta Valle F, et al. Update of the NGF saga. J Neurol Sci 1995;130:119-127.
24. Hellweg R, Hartung HO. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990;26:258-267,
25. Jakobsen J, Brimijoin S, Skau K, et al. Retrograde axonal transport of transmitter enzymes, fructose-labeled protein and nerve growth factor in streptozotocin-diabetic rats. Diabetes 1981;30: 797-803.
26. 125I] nerve growth factor in ileal mesenteric nerves in vitro: effect of streptozotocin diabetes. Brain Res 1986;378: 325-336.
27. Willars GB, Calcutt NA, Compton AM, Tomlinson DR. Substance P levels in peripheral nerve, skin, atrial myocardium and gastrointestinal tract of rats with long-term diabetes mellitus. J Neurol Sci 1989;91:153-164.
28. Diemel LT, Stevens EJ, Willars GB, Tomlinson DR. Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes: effects of insulin and aldose reductase inhibition. Neurosci Lett 1992;137:253-256.
29. Diemal LT, Brewster WJ, Fernyhough P, Tomlinson DR. Expression of neuropeptides in experimental diabetes: effects of treatment with nerve growth factor or brain-derived neurotrophic factor. Mol Brain Res 1994;21:171-175.
30. Hellweg R, Wohrle M, Hartung HO, et al; Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogenic pancreatic islet transplantation. Neurosci Lett 1991; 125:1-4.
31. Chen X, Levine JD. Altered temporal pattern of mechanically evoked C-fiber activity in a model of diabetic neuropathy in the rat. Neuroscience 2003;121:1007-1015.
32. Elias KA, Cronin MJ, Stewart TA, Carlsen RC. Peripheral neuropathy in transgenic diabetic mice. Restoration of C-fiber function with human recombinant nerve growth factor. Diabetes 1998;47:1637-1642.
33. Parry GP, Kozu H. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy. Neurology 1990;40: 1446-1449.
34. Zhang W, Slusher B, Murakawa Y, et al. GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB-Wor-rat. J Neurol Sci 2002;194:21-28.
35. Murakawa Y, Zhang W, Pierson CR, et al. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev 2002;18:473-483.
36. Burchiel KJ, Russel LC, Lee RP, Sima AAF. Spontaneous activity of primary afferent neurons in diabetic BB-Wistar rats. A possible mechanism of chronic diabetic pain. Diabetes 1985;34: 1210-1213.
37. Arendt-Nielsen L, Sonnenborg FA, Andersen OK. Facilitation of the withdrawal reflex by repeated transcutaneous electrical stimulation: an experimental study on central integration in humans. Eur J Appl Physiol 2000;81:165-173.
38. Sugimoto K, Murakawa Y, Zhang W-X, et al. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diabetes Metab Res Rev 2000;16:354-367.
39. Sugimoto K, Murakawa Y, Sima AAF. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord. J Peripher Nerv Syst 2002;7:44-53.
40. Sima AAF. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 2003;60:2445-2464.
41. Dickenson AH, Matthews EA, Suzuki R. Neurobiology of neuropathic pain: mode of action of anticonvulsants. Eur J Pain 2002;6(suppl A):51-60.
42. Hirade M, Yasuda H, Omatsu-Kanbe M, et al. Tetrodotoxin-resistant sodium channels of dorsal root ganglion neurons are readily activated in diabetic rats. Neuroscience 1999;90: 933-939.
43. Kitamura T, Kimura K, Jung BD, et al. Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 2002;366:737-744.
44. Kitamura T, Kimura K, Makondo K, et al. Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 2003;46:1698-1705.
45. Reico-Pinto E, Rechler MM, Ishii DN. Effects of insulin, insulin-like growth factor II, and nerve growth factor on neurite formation and survival of cultured sympathetic and sensory neurons. J Neurosci 1986;6:1211-1219.
46. Ishii DN, Reico-Pinto E, Spinelli W, et al. Neurite formation modulated by nerve growth factor, insulin, and tumor promotor receptors. Int J Neurosci 1985;26:109-127.
47. Sima AAF, ed. Trophic factors and inflammatory mediators in diabetic complications. Exp Diabesity Res 2003;4:203-312.
48. Reico-Pinto E, Lang FF, Ishii DN. Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells. Proc Natl Acad Sci U S A 1984;81:2562-2566.
49. Tomlinson DR, Fernyhough P. Neurotrophism in diabetic neuropathy. In: Sima AAF, ed. Frontiers in animal diabetes research. Chronic complications in diabetes. Amsterdam: Harwood Academic Publishers, 2000:167-182.
50. Fernyhough P, Diemel LT, Tomlinson DR. Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 1998;41:300-306.
51. Brewster WJ, Fernyhough P, Diemel LT, et al. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 1994;17:321-325.
52. Ishii DN, Lupien SB. Insulin-like growth factor replacement therapy for diabetic neuropathy: experimental basis. Exp Diabesity Res 2003;4:257-269.
53. Sima AAF, Li Z-G, Zhang W. The IGF system and neurological complications in diabetes. Exp Diabesity Res 2003;4: 235-256.
54. Barrett GL. The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol 2000;61:205-229.
55. Barrett GL, Georgiou A. The low-affinity nerve growth factor receptor p75 (NGF) mediates death of PC12 cells after nerve growth factor withdrawal. J Neurosci Res 1996;45:117-128.
56. Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003;52:162-171.
57. Russell JW, Sullivan KA, Windebank AJ, et al. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999;6:347-363.
58. Cheng C, Zochodne DW. Sensory neurons with activated caspase-3 survive long term experimental diabetes. Diabetes 2003;52:2363-2371.
59. Li Z-G, Zhang W, Sima AAF. C-peptide prevents hippocampal apoptosis in type 1 diabetes. Exp Diabesity Res 2002;3: 241-246.